Biotech & pharma AI Systems | Next Gen System

Biotech & pharma

Biotech & pharma
Healthcare · production work
Healthcare

Biotech & pharma

Ops that can be replayed: sample logs, vendor packs, and SOP extracts.

Built for biotech and pharma ops teams who need audit trails on repetitive work.

Regulated ops still run on inboxes and shared folders. We automate the repetitive steps—logs, vendor packs, SOP tables—and give agents a scoped job: draft the next action, wait on a human for writes that matter.

Human-in-the-loop writes Source citations GxP-aware scope Expand after one lane
Where we work

Typical jobs in Biotech & pharma

Specific production work—not a generic “we do AI for this sector” list.

Sample & vendor logs

Repetitive posts with owners and timestamps.

SOP & pack extraction

Study and invoice scans become tables with an edit audit.

Scoped agents

Draft the next step; wait on humans for regulated writes.

Replayable ops

QA can see what the job did and who approved it.

How we show up

The work behind the sector label

Next Gen System treats Biotech & pharma as operating jobs with owners, integrations, and a handoff—not a slide of industry logos.

QA will ask what happened. Jobs carry timestamps, owners, and source files. That is the difference between a helpful script and something you can defend.

Extraction turns study packs and invoices into tables. Agents may pull facts from allowed systems and propose a step. They do not unsupervised-write into GxP systems.

We start with one high-volume ops lane, prove the trail, then expand. Tool theatre does not survive an audit.

Biotech & pharma operations
What changes

Outcomes operators can feel

QA will ask what happened. The answer should be a trail—not a heroic inbox search.

Ops steps you can replay

Logs, vendor packs, and SOP tables carry timestamps, owners, and source files.

Less inbox logistics

Repetitive posts leave the shared folder. People stay on the checks that matter.

Extracted packs with edit history

Study and invoice scans become tables. Corrections are visible, not overwritten silently.

Agents that wait on approval

They draft the next action. Regulated writes stay human unless you explicitly own a different control.

Biotech & pharma outcomes
[ How it works ]

From discovery to production in three steps

We scope the win, build with evals, and hand over a system your team can run.


01

Discover & Prioritize

We map high-ROI chatbot, voice, automation, or data use cases—then pick the first win that can reach production.

02

Build & Evaluate

We design the system, integrate your stack, and prove quality with evals before wider rollout.

03

Launch & Operate

We ship with monitoring, feedback loops, and a clear runbook so your team can own the system.


Good fit

When to engage

  • A named ops process with volume
  • Quality willing to define the audit
  • Clear line between draft and write
Not a fit

When to wait

  • Unsupervised writes into GxP systems
  • No process owner
  • A science experiment with no ops lane
FAQ

Questions teams ask before they buy

Straight answers for Biotech & pharma work with Next Gen System.

Not unless you explicitly own that write and the controls. Default is draft + approve.

Scope, environments, and evidence are part of the engagement—not an afterthought slide.

Yes. We integrate the queue you already have rather than replacing the stack for sport.

Ready to map Biotech & pharma work?

We will pick the first production job, the systems it must touch, and what “done” looks like for your operators.

Need a Consultation?

Share your use case. We respond within one business day.

+1